Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 14,123 shares at $0.88 ($12K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Seasonal sale ($12k) by SVP, Chief Medical Officer — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.88 | 1,110 | $977 | 7.9% |
| 2 | $0.88 | 6,400 | $6K | 45.3% |
| 3 | $0.88 | 6,613 | $6K | 46.8% |
| Total | $0.88 avg | 14,123 | $12K | 100% |
| Filing → |
| AKBA | SELL | 2025-02-04 | $163K | — | Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |